Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding (original) (raw)
Faculty of 1000 evaluation for Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ
Dinesh Nath
F1000 - Post-publication peer review of the biomedical literature, 2018
View PDFchevron_right
Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ
Joseph Noel
Proceedings of the National Academy of Sciences of the United States of America, 2017
View PDFchevron_right
Flexible ligand recognition of peroxisome proliferator-activated receptor-γ (PPARγ)
Hiroaki Tokiwa
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Flexible ligand recognition of peroxisome proliferator-activated receptor-? (PPAR?)
Hiroaki Tokiwa
Bioorg Medicinal Chem Letter, 2010
View PDFchevron_right
Crystal Structure of the Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligand Binding Domain Complexed with a Novel Partial Agonist: A New Region of the Hydrophobic Pocket Could Be Exploited for Drug Design
giuseppe fracchiolla
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Analysis of the Critical Structural Determinant(s) of Species-Selective Peroxisome Proliferator-Activated Receptor Alpha (PPARα)-Activation by Phenylpropanoic Acid-Type PPARα Agonists
Hiroyuki Miyachi
Bioorganic & Medicinal Chemistry Letters, 2003
View PDFchevron_right
Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ
Letizia Giampietro
Journal of Structural Biology, 2015
View PDFchevron_right
Structural Determinants of the Agonist-independent Association of Human Peroxisome Proliferator-activated Receptors with Coactivators
Ferdinand Molnar
Journal of Biological Chemistry, 2005
View PDFchevron_right
A simple method to screen ligands of peroxisome proliferator-activated receptor δ
Sang-gi Paik
European Journal of Pharmaceutical Sciences, 2006
View PDFchevron_right
Identification of a PPAR Delta Agonist: An In Silico Approach Towards Drug Design for Metabolic Syndrome
Asha Abraham
Prospects in Bioscience: Addressing the Issues, 2012
View PDFchevron_right
Insights into the Mechanism of Partial Agonism: CRYSTAL STRUCTURES OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR LIGAND-BINDING DOMAIN IN THE COMPLEX WITH TWO ENANTIOMERIC LIGANDS
F. Loiodice
Journal of Biological Chemistry, 2007
View PDFchevron_right
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
W. Li
Expert Opinion on Therapeutic Targets, 2017
View PDFchevron_right
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode
Giorgio Pochetti
Scientific Reports, 2016
View PDFchevron_right
A Dominant Negative Human Peroxisome Proliferator-Activated Receptor (PPAR)α Is a Constitutive Transcriptional Corepressor and Inhibits Signaling through All PPAR Isoforms
M. Gurnell
Endocrinology, 2005
View PDFchevron_right
Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ)
Helmut Blöcker
PLoS ONE, 2011
View PDFchevron_right
Ligand-induced Peroxisome Proliferator-activated Receptor alpha Conformational Change
Mark Zabriskie
Journal of Biological Chemistry, 1997
View PDFchevron_right
Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases
Balint Balint
Endocrine, metabolic & immune disorders drug targets, 2006
View PDFchevron_right
Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism
John Bruning
Structure , 2018
View PDFchevron_right
Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling
Amiram Goldblum
Scientific Reports
View PDFchevron_right
Insights into the Mechanism of Partial Agonism CRYSTAL STRUCTURES OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ LIGAND-BINDING DOMAIN IN THE COMPLEX WITH TWO ENANTIOMERIC LIGANDS
Fernando Mazza
The Journal of Biological Chemistry, 2007
View PDFchevron_right
Combined Simulation and Mutagenesis Analyses Reveal the Involvement of Key Residues for Peroxisome Proliferator-activated Receptorα Helix 12 Dynamic Behavior
W. Li
Journal of Biological Chemistry, 2007
View PDFchevron_right
Ligand-enhanced expression and in-cell assay of human peroxisome proliferator-activated receptor alpha ligand binding domain
Kieran Rimmer
Protein Expression and Purification, 2010
View PDFchevron_right
Molecular Mechanism of Peroxisome Proliferator Activated Receptors During Inflammation
Soheila Rahgozar
Genetics in the Third Millennium, 2011
View PDFchevron_right
Ligand-induced Peroxisome Proliferator-activated Receptor α Conformational Change
Mark Zabriskie
Journal of Biological Chemistry, 1997
View PDFchevron_right
Two-dimensional quantitative structure-activity relationship studies on bioactive ligands of peroxisome proliferator-activated receptor δ
Drago Beslo
Journal of the Brazilian Chemical Society, 2011
View PDFchevron_right
Selective peroxisome proliferator-activated receptor (PPAR ) modulation as a strategy for safer therapeutic PPAR activation
Natia Peradze
American Journal of Clinical Nutrition, 2010
View PDFchevron_right
Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation
Shizuya Yamashita
The American Journal of Clinical Nutrition, 2009
View PDFchevron_right